Medicine and Health
The onset of the next pandemic may occur sooner than anticipated. What will the appearance be?
Half a decade ago, the notion of a global shutdown lasting for weeks would have been inconceivable. However, the concept of mass graves in New York City, a US Republican administration implementing a seemingly universal basic income, and a small number of individuals self-administering an ineffective horse dewormer to treat a virus would also be considered.
Presently, all of it appears to be not just feasible but outdated information. Having experienced and overcome the COVID-19 epidemic, what is the next anticipated event in the ongoing pandemic?
From whence will the forthcoming pandemic originate?
If we possessed knowledge of the nature and timing of the upcoming epidemic, we would take proactive measures to address it. However, the current situation necessitates a hopeful outlook and proactive preparation for potential negative outcomes.
“Undoubtedly, there are individuals who express concerns that this could potentially induce panic,” stated Tedros Adhanom Ghebreyesus, the Director-General of the World Health Organization (WHO), during a panel in January 2024 regarding “Disease X,” a provisional term for the yet-to-be-identified disease that is expected to have a widespread impact on the world in the near future.
He presented a counterargument. “It is more advantageous to proactively anticipate potential events, as they have occurred frequently in our past, and make necessary preparations.” We should not confront situations without enough preparation.
What is the consensus among specialists regarding the probable nature of disease X? There are several candidates in the competition: “We compile a yearly inventory of emerging diseases,” Ghebreyesus clarified, “and MERS, Zika, Ebola, and others could potentially be included.” COVID could be referred to as the inaugural disease X.
Possible scenarios for the emergence of the forthcoming pandemic encompass a spectrum of possibilities, spanning from speculative catastrophic scenarios wherein global warming triggers the release of previously unidentified viruses from arctic ice, akin to the depiction in the Chris Pratt time travel film, to alarmingly plausible instances of disease transmission from the animal kingdom, akin to the events that transpired shortly prior to the previous pandemic.
If you have observed a consistent pattern among those choices, you are correct: due to climate change, deforestation in the Amazon and Africa, and the increasing intrusion of human settlements into the natural environment, numerous experts believe that the occurrence of the next zoonotic disease pandemic is highly likely.
According to Nathalie MacDermott, a clinical lecturer in infectious diseases at King’s College London, the current circumstances are conducive to the occurrence of epidemics.
According to her statement, the duration of the situation could range from two years to 20 years or even longer. However, she emphasized the importance of maintaining vigilance. It is imperative to maintain a state of vigilance, preparedness, and readiness to make sacrifices once more.
How can we address this issue?
In the absence of knowledge on the kind or timing of the upcoming pandemic, how can we effectively make the necessary preparations? Indeed, it is simpler than one may anticipate: “We can make arrangements for unforeseen circumstances,” stated Ghebreyesus; “there are fundamental actions that can be taken.”
He proposed the establishment of an early warning system or the enhancement of preparedness plans. “Due to the COVID pandemic, our hospitals were overwhelmed, both in terms of physical capacity and staff,” he emphasized.
The speaker further asserted that the COVID pandemic has brought to light some deficiencies within medical supply chains, perhaps leading to the closure of gaps.
Adam Kucharski, co-director of the Centre for Epidemic Preparedness and Response at the London School of Hygiene and Tropical Medicine, stated to Sky News that the UK’s NHS COVID app showed great potential for containing the spread of the pandemic.
He acknowledged that it would take difficult conversations regarding the compromises between public health and personal privacy. “However, by utilizing the digital contact tracing infrastructure present in certain Asian countries, it is possible to restrict disruption to individuals who are at a greater risk during a specific outbreak, rather than resorting to general measures.”
Frankly speaking, everything seemed highly feasible. Is it being done?
Navigating the upcoming epidemic
With minimal logistical planning and the inclusion of AI ethics courses, we should undoubtedly successfully navigate the upcoming pandemic. Is that correct?
Regrettably, that appears improbable at present. John Bell, a prominent immunologist and part of the UK’s Covid vaccination team during the epidemic, expressed in The Independent last year that despite our extensive knowledge, we are not adequately prepared for the upcoming pandemic.
He cautioned that the forthcoming epidemic has the potential to be considerably more catastrophic than its predecessor. It is imperative that we maintain a perpetual level of preparedness for forthcoming significant health crises, as failure to take action at present will result in a lack of forgiveness.
In the United States, the establishment of a novel governmental entity dedicated to global health and the prevention of pandemics may appear to be a positive progression. However, numerous commentators have highlighted that the country lacks essential infrastructure to withstand a pandemic. Notably, there is no universal healthcare system, and European readers should take a moment to understand that there is no entitlement to paid sick leave. Undoubtedly, during the COVID pandemic, about 25% of Americans had to make a decision between working while ill or forfeiting a day’s salary.
Despite experiencing significant global repercussions due to the global spread of COVID-19, the United States as an institution appears to have a notable reluctance to acquire substantial knowledge from the pandemic. Recent modeling estimates indicate that treatments such as social distancing and mask-wearing have proven to be highly effective in mitigating the transmission of the pandemic. Similarly, vaccines have demonstrated remarkable efficacy, resulting in the preservation of about 20 million lives within the initial year of their introduction. However, the country is witnessing the ongoing expansion of anti-vacxx and anti-science movements, which are permeating politics and exerting influence on legislation at both municipal and state levels.
Put simply, it appears unappealing.
The subsequent periods of lockdown
The Covid pandemic took us off guard, and there is a possibility that we may be taken off guard once more. What will the appearance of that be? A recurrence of the events of 2020, or an entirely distinct occurrence?
It is indisputable that significant changes have occurred since 2019, prior to the widespread awareness of the terms “novel coronavirus” or “Covid-19”. Irrespective of their level of effectiveness or extent of implementation, it is really accurate to say that numerous countries have already established pandemic infrastructure that was previously absent. This includes the implementation of contact-tracing applications and the provision of more flexible work arrangements for employees.
If the supply chain difficulties are rectified promptly, vaccine rollouts should be expedited. According to Devi Sridhar, the chair of global public health at the University of Edinburgh and co-chair of the US National Academy of Sciences’ committee on advancing pandemic and seasonal influenza vaccine preparedness and response in 2021, the majority of governments are actively pursuing the objective of containing the spread of a virus within a 100-day timeframe. This timeframe allows for the approval, manufacturing, and distribution of scientific interventions, such as vaccines, diagnostic tools, or treatments, to the general public. This statement was published in The Guardian during the current week.
“In the United States, the recommended duration is 130 days from the identification of a pathogen until the entire population of the United States is provided with a vaccine,” she clarified, “and 200 days until there is a sufficient global supply.”
The nature of future lockdowns may vary significantly depending on geographical location, maybe resulting in the absence of lockdown measures altogether. “Shutdowns are a drastic policy measure that numerous governments employed in 2020 as a means to address the healthcare crisis,” Sridhar stated. “We currently have the opportunity to enhance containment methods and investigate strategies to ensure the safe operation of schools and businesses through more accurate public health interventions. These interventions should focus on improving understanding of transmission (such as increasing ventilation), diagnostics (testing for infectiousness), and data collection (surveillance of community prevalence).”
The successful implementation of preparedness procedures, as advocated by public health organizations over an extended period, is contingent upon the active engagement of governments and, when applicable, the business sector. This implies that—what about the upcoming pandemic? The appearance of it is uncertain.
Medicine and Health
A recently identified strain of deadly fungus poses a significant risk to public health
Researchers have recently discovered a new group of Candida auris, a potentially dangerous pathogen. The finding increases the total number of identified clades of the fungus, which is a newly emerging superbug resistant to multiple drugs, to six.
Candida auris is a strain of yeast that has the potential to cause serious illness and is frequently impervious to antifungal drugs. While individuals who are in good health generally do not fall ill, the transmission of the disease is highly prevalent within medical institutions and poses a significant risk to individuals with compromised immune systems. The yeast can induce a variety of conditions ranging from superficial infections of the skin to more severe and life-threatening illnesses, such as bloodstream infections. Due to its high level of resistance to multiple drugs, treating it can be challenging, and in some cases, even impossible.
The authors state that the pathogen is a significant global public health threat due to its widespread distribution, resistance to multiple drugs, high ability to spread, tendency to cause outbreaks, and high mortality rate. Although infections are still relatively uncommon, there has been a significant increase in cases in recent years.
Previously, the fungus had been categorized into five distinct clades, each located in different geographic regions: South Asia, East Asia, Africa, South America, and Iran.
In April 2023, doctors from the Singapore General Hospital identified a patient carrying a unique strain of C. auris as part of a routine screening program, adding it as the most recent clade to be discovered. Typically, these cases arise from individuals who have recently traveled, but this particular patient had not traveled outside the country for a period of two years, which raised some concerns.
Upon conducting a genetic analysis of the strain, the researchers determined that it did not align with any of the five known clades of the fungus. Therefore, it can be concluded that the strain belongs to a previously unidentified, sixth clade. Subsequently, they conducted tests on strains obtained from previous patients and identified two additional isolates of this particular group of C. auris in Singapore, as well as another isolate in Bangladesh.
The extent of the new clade’s prevalence and its potential to cause invasive infections and outbreaks remains uncertain at present. However, the researchers emphasize the importance of promptly identifying and controlling it in order to safeguard patient well-being.
“The ramifications of this breakthrough transcend the confines of the laboratory.” “Given the recent discovery of the sixth Candida auris clade, it is imperative to enhance surveillance capability or create new methods to strengthen existing surveillance strategies. This will enable health care facilities to closely monitor its emergence and effectively control its spread,” stated Dr. Karrie Ko, co-first author of the study.
Fortunately, the cases described in the study remained vulnerable to all antifungals that were tested. This should alleviate concerns about a pandemic similar to the one depicted in The Last Of Us. However, it is evident that the threat of C. auris is persistent. Therefore, additional efforts are required to identify new strains, monitor their spread, and control any negative clinical consequences.
The research is published in The Lancet Microbe journal.
Medicine and Health
What makes your chest hurt when something makes you jump?
Have you ever been scared so badly that you grabbed your chest? You feel like someone or something just zapped you behind the sternum. As you rest, you lean against the wall and think about why your friend is such a jerk and why you can feel it in your chest whenever you get scared.
People often use words like “heart-stopping” when they write fiction about fear, but the science of fear tells us that this isn’t what’s happening because it wouldn’t make sense. Our bodies are getting ready to deal with an impending threat when we’re scared, and going into cardiac arrest wouldn’t help us get very far if a lion was after us.
What do we do when we’re scared?
The sympathetic nervous system is what gets you excited when something makes you jump. It’s a tool inside our bodies that releases hormones and changes the way our bodies work to get us ready for the fight-or-flight response.
One important part is adrenaline, which is also known as epinephrine. The adrenal glands squeeze it out into the blood. The heart starts beating faster, sending more blood to your muscles and organs right away. Because they need all the oxygen they can get if they want to get away from a dangerous animal.
How do you feel when you go for a run?
Anyone who has ever used an EpiPen knows how bad it is to feel a sudden rush of adrenaline. It’s a stress hormone that makes you feel nervous and anxious, like you would before doing a bungee jump. Getting a rush when you think about a traumatic event from the past can be a sign of PTSD.
A medicine called adrenaline is used because it can help people who are having a medical emergency. If you have anaphylaxis from an allergen like peanuts, this can help because it can open your airway. Because it changes the strength and speed of heartbeats, it is also sometimes used to help people who are having a cardiac arrest.
When your adrenaline level goes up quickly, you may feel shaky, your heart beat quickly, and your chest get tight. When you add in the fact that you’re more alert, you become very aware of the changes in your body. This is especially clear when you’re not in danger, like when your partner surprised you at home when you thought you were alone.
When you’re scared, your sympathetic nervous system usually kicks in, which is normal. But, some heart conditions can get worse when you’re scared. Should anyone be having chest pain or ongoing discomfort, they should see a doctor. In the end, it is possible to be so scared that you die.
This article is not meant to be a replacement for medical advice, diagnosis, or treatment from a trained professional. If you have questions about a medical condition, you should always talk to a qualified health professional.
Medicine and Health
The Lacks family is suing again over her “stolen” cells
The family of Henrietta Lacks has filed a new lawsuit against two sizable drug companies for using her genetic material without her consent.
In the US District Court for the District of Maryland, Lacks’ living relatives are suing Novartis Pharmaceuticals Corporation, Novartis Gene Therapies, Inc., Viatris, Inc., and its subsidiary, Mylan Pharmaceuticals. They say the companies have used the “stolen” HeLa cell line to make hundreds of patents and have made a lot of money from it.
The suit wants the money made from using these cells to be “rightfully transferred” to Henrietta Lacks’s estate.
Novartis and Viatris chose to sell Henrietta Lacks’ living genetic material. Lacks was a black grandmother, community leader, and woman whose doctors took her tissue without her knowledge or permission, according to Chris Ayers, an attorney at Seeger Weiss LLP who is representing the Lacks family.
Ayers added, “We will keep looking for justice for Mrs. Lacks and her family.”
Henrietta Lacks died on October 4, 1951, from cervical cancer. She was 31 years old. Some of her cells are still alive today. A doctor at Johns Hopkins Hospital took a sample of her cervical cells without her knowledge just before she died. They were doing a cancer check. It was seen that her cells kept multiplying quickly, even after most of the cells in other samples would have died without their host.
Because scientists saw the potential, they found that these cells could be a cheap and easy way to help researchers do more research. The “HeLa immortal cell line” is what scientists call these cells, and they are very useful for biomedical research.
Over 75,000 scientific studies around the world have used these cells, which amount to about 55 million tons. They have been very important in making progress in areas like polio vaccines, cancer treatments, HIV/AIDS treatments, and much more.
All of this was done, though, without Lacks’ knowledge or permission. For many years, her family also didn’t know that the cells were being used for business.
Selling HeLa cells for money brings up important issues in medical ethics and genetics. As a black woman living in America in the 1950s, Lacks’ case shows how medical racism still affects minorities who aren’t getting enough help.
Even though a lot of people know about these problems, HeLa cells are still used in medical research for profit, which makes some companies a lot of money.
“Now that everyone knows Henrietta Lacks’ story, it’s shocking, but not surprising, that drug companies like Novartis and Viatris are still making money off of the deeply unethical origins of HeLa cells and the disturbing history of medical racism,” said Chris Seeger, another lawyer for the family.
A historic deal was made by Lacks’ family in 2023 after they sued Thermo Fisher Scientific, Inc., another biotech company, in the US District Court for the District of Baltimore. During that time, the lawyers said that the settlement was only the beginning and that there could be many more lawsuits about the use of HeLa cells.
- Gadgets9 years ago
Why the Nexus 7 is still a good tablet in 2015
- Mobile Devices9 years ago
Samsung Galaxy Note 4 vs Galaxy Note 5: is there room for improvement?
- Editorials9 years ago
Samsung Galaxy Note 4 – How bad updates prevent people from enjoying their phones
- Mobile Devices9 years ago
Nexus 5 2015 and Android M born to be together
- Gaming9 years ago
New Teaser For Five Nights At Freddy’s 4
- Mobile Devices9 years ago
Google not releasing Android M to Nexus 7
- Gadgets10 years ago
Moto G Android 5.0.2 Lollipop still has a memory leak bug
- Mobile Devices9 years ago
Nexus 7 2015: Huawei and Google changing the game